Skip to main content

Table 1 Clinical pathological features of patients with cervical cancer

From: MiR-218 produces anti-tumor effects on cervical cancer cells in vitro

Factors

IDO1 levels

P values

Higher

Lower

Age (years)

< 50

11

5

0.893

≥ 50

14

7

FIGO stages

I, II

7

10

0.002**

III, IV

18

2

Histological grade

Well/middle differentiated

8

8

0.046**

Low differentiated

17

4

  1. **P < 0.01, chi-square test